Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Mega Genomics's Enterprise Value is HK$1,842.6 Mil.
Mega Genomics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$40.8 Mil. Therefore, Mega Genomics's EV-to-EBIT ratio for today is 45.16.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Mega Genomics's Enterprise Value is HK$1,842.6 Mil.
Mega Genomics's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$57.3 Mil. Therefore, Mega Genomics's EV-to-EBITDA ratio for today is 32.14.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Mega Genomics's Enterprise Value is HK$1,842.6 Mil.
Mega Genomics's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$165.5 Mil. Therefore, Mega Genomics's EV-to-Revenue ratio for today is 11.13.
Mega Genomics Enterprise Value Historical Data
The historical data trend for Mega Genomics's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Mega Genomics's Enterprise Value
For the Diagnostics & Research subindustry, Mega Genomics's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mega Genomics's Enterprise Value Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Mega Genomics's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Mega Genomics's Enterprise Value falls into.
Mega Genomics Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Mega Genomics's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mega Genomics (HKSE:06667) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Mega Genomics's current Enterprise Value is HK$1,842.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Mega Genomics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$40.8 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Mega Genomics's current Enterprise Value is HK$1,842.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Mega Genomics's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$57.3 Mil.
Mega Genomics's current Enterprise Value is HK$1,842.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Mega Genomics's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$165.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mega Genomics Enterprise Value Related Terms
Thank you for viewing the detailed overview of Mega Genomics's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Mega Genomics Ltd is a genetic testing platform company in China with a focus on consumer genetic testing and cancer screening services. The company has launched dozens of testing services, covering a wide range of fields such as nutrition and metabolism, cancer risk assessment, chronic disease susceptibility, cancer screening and infectious disease diagnosis, to meet consumers' growing preventive medical needs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06667 has been successfully added to your